These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
These Analysts Increase Their Forecasts On Abbott Laboratories After Better-Than-Expected Q3 Earnings
Abbott projects full-year 2024 adjusted EPS of $4.64-$4.70 versus prior guidance of $4.61-$4.71 and consensus of $4.66. Abbott forecasts that in the fourth quarter of 2024, the adjusted EPS will be $1.31-$1.37 versus the consensus of $1.20.Abbott Laboratories (NYSE:ABT) reported better-than-expected third-quarter results on Wednesday.
雅培實驗室（紐交所：ABT）週三公佈了好於預期的第三季度業績。
The company posted sales of $10.64 billion, up 4.9% year over year, beating the consensus of $10.55 billion. Abbott's adjusted diluted earnings per share was $1.21, beating the analyst estimates of $1.20.
該公司銷售額爲106.4億美元，同比增長4.9%，超過了105.5億的共識。雅培的調整後每股稀釋收益爲1.21美元，超過了分析師預期的1.20美元。
"Our results this quarter demonstrate the strength of our diversified business model," said Robert Ford, chairman and CEO of Abbott. "We're well-positioned to achieve the upper end of our initial guidance ranges for the year and have great momentum heading into next year."
「本季度的業績表明了我們多元化業務模式的實力，」雅培公司董事長兼首席執行官羅伯特·福特表示。「我們有望實現今年初指導範圍的最高端，並在明年開局良好。」
Abbott projects full-year 2024 adjusted EPS of $4.64-$4.70 versus prior guidance of $4.61-$4.71 and consensus of $4.66. Abbott forecasts that in the fourth quarter of 2024, the adjusted EPS will be $1.31-$1.37 versus the consensus of $1.20.
雅培預計2024財年調整後每股收益爲4.64美元至4.70美元，而之前的指導範圍爲4.61美元至4.71美元，市場共識爲4.66美元。雅培預測在2024年第四季度，調整後每股收益將爲1.31美元至1.37美元，市場共識爲1.20美元。
Abbott shares gained 1.5% to close at $117.82 on Wednesday.
週三，雅培股價上漲了1.5%，收於117.82美元。
These analysts made changes to their price targets on Abbott following earnings announcement.
這些分析師在雅培發佈業績後調整了其價格目標。
- Morgan Stanley analyst David Lewis maintained Abbott with an Equal-Weight and raised the price target from $107 to $117.
- Piper Sandler analyst Adam Maeder maintained the stock with an Overweight and boosted the price target from $131 to $133.
- 摩根士丹利分析師大衛·劉易斯維持對雅培的等權評級，並將目標股價從107美元上調至117美元。
- 派傑投資分析師亞當·梅德維持該股票的股票等級爲增持，並將目標股價從131美元提高至133美元。
Considering buying ABT stock? Here's what analysts think:
考慮購買雅培股票？以下是分析師的看法：
- Top 3 Risk Off Stocks Which Could Rescue Your Portfolio This Quarter
- 前三名避險股票，有可能在本季度挽救您的投資組合
譯文內容由第三人軟體翻譯。
